Compound to Clinic? A Preclinical High-throughput Screening Pathway To Expedite Drug Discovery in Bladder Cancer. Conroy S, Nguyen AHT. Eur Urol 2022 May 5. pii: S0302-2838(22)01811.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Conroy S, Nguyen AHT. Compound to Clinic? A Preclinical High-throughput Screening Pathway To Expedite Drug Discovery in Bladder Cancer. Eur Urol 2022 May 5. pii: S0302-2838(22)01811.
PMID: 35527064